Skin Hydration Sensor for Anemia, Sickle Cell
Study Summary
This trial will test a new sensor to see if it can accurately measure hydration levels in patients with sickle cell disease. The sensor could be used to help guide hydration therapy for these patients.
- Anemia, Sickle Cell
Treatment Effectiveness
Effectiveness Progress
Study Objectives
19 Primary · 0 Secondary · Reporting Duration: At a regularly scheduled clinical appointment, approximately 2 hours
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Skin Hydration Sensor
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Skin Hydration Sensor · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 20th, 2021
Last Reviewed: November 18th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.